Skip to main content
. Author manuscript; available in PMC: 2021 Feb 5.
Published in final edited form as: J Minim Invasive Gynecol. 2019 Nov 1;27(2):280–286. doi: 10.1016/j.jmig.2019.10.020

Table 1.

Summary of genome-wide significant loci associated with endometriosis identified in recent GWAS meta-analyses

Chr SNP BP RA OR (95% CI) p value Associated gene/cytoband
Previously reported loci
1 rs12037376 22462111 A 1.16 (1.12–1.19) 8.87 × 10−17 WNT4/1p36.12
2 rs11674184 11721535 T 1.13 (1.10–1.15) 2.67 × 10−17 GREB1/2p25.1
2 rs10167914 113563361 G 1.12 (1.08–1.15) 1.10 × 10−9 IL1A/2q13
2 rs6546324 67856490 A 1.08 (1.05–1.11) 3.01 × 10−8 ETAA1/2p14
4 rs1903068 56008477 A 1.11 (1.07–1.13) 1.04 × 10−11 KDR/4q12
6 rs760794 19790560 T 1.09 (1.06–1.12) 1.79 × 10−10 ID4/6p22.3
7 rs12700667 25901639 A 1.10 (1.07–1.13) 9.08 × 10−10 7p15.2
9 rs1537377 22169700 C 1.09 (1.06–1.12) 1.33 × 10−10 CDKN2B-AS1/9p21.3
12 rs4762326 95668951 T 1.08 (1.05–1.11) 2.20 × 10−9 VEZT/12q22
2 rs1250241 216295312 T 1.06 (1.03–1.09) 6.20 × 10−5 FN1/2q35
6 rs1971256 151816011 C 1.09 (1.06–1.13) 3.74 × 10−8 CCDC170/6q25.1
6 rs71575922 152554014 G 1.11 (1.07–1.15) 2.02 × 10−8 SYNE1/6q25.1
7 rs74491657 46947633 G 1.08 (1.03–1.13) 1.23 × 10−3 7p12.3
11 rs74485684 30242287 T 1.11 (1.07–1.15) 2.00 × 10−8 FSHB/11p14.1
Novel loci
1 rs12030576 115817221 G 1.07 (1.05–1.09) 5.2 × 10−13 NGF/1p13.2
1 rs1209731 169324793 C 1.19 (1.12–1.26) 2.0 × 10−8 ATP1B1-F5/1q24.2
1 rs1894692 169467654 A 1.18 (1.13–1.24) 2.88 × 10−13 SLC19A2/1q24.2
1 rs495590 172152202 G 1.07 (1.05–1.10) 6.73 × 10−10 DNM3/1q24.3
4 rs2510770 95479372 A 1.05 (1.03–1.06) 8.25 × 10−10 PDLIM5/4q22.3
5 rs13177597 82052282 G 1.06 (1.04–1.08) 1.30 × 10−8 ATP6AP1L/5q14.2
6 rs1595344 74611632 G 1.05 (1.03–1.07) 1.2 × 10−8 CD109/6q13
6 rs2226158 125995467 G 1.05 (1.03–1.07) 2.6 × 10−8 HEY2/6q22.31
7 rs62468795 23530051 G 1.10 (1.07–1.14) 8.05 × 10−9 IGF2BP3/7p15.3
8 rs10090060 75257608 A 1.08 (1.06–1.11) 5.72 × 10−11 GDAP1/8q21.11
8 rs6468654 100062724 C 1.06 (1.04–1.08) 2.5 × 10−8 OSR2-VPS13B/8q22.2
10 rs1802669 21827796 A 1.07 (1.05–1.10) 5.52 × 10−9 MLLT10/10p12.31
10 rs796945 90150837 C 1.07 (1.05–1.10) 1.78 × 10−9 RNLS/10q23.31
11 rs7924571 32350027 C 1.06 (1.04–1.08) 3.5 × 10−8 WT1/11p13
12 rs17727841 102809630 G 1.06 (1.04–1.08) 5.33 × 10−11 IGF1/12q23.2
14 rs7151531 93113547 C 1.07 (1.04–1.10) 3.80 × 10−8 RIN3/14q32.12
15 rs4923850 40352278 A 1.05 (1.04–1.06) 3.07 × 10−13 BMF/15q15.1
17 rs66683298 46277748 C 1.08 (1.06–1.11) 1.73 × 10−10 SKAP1/17q21.32
17 rs76731691 63960269 G 1.08 (1.05–1.11) 9.27 × 10−9 CEP112/17q24.1
X rs13441059 70108889 A 1.05 (1.03–1.07) 4.1 × 10−8 TEX11-SLC7A3/Xq13.1

BP = genomic position in base pairs shown relative to GRCh37 (hg19); Chr = chromosome; CI = confidence interval; GWAS = genome-wide association study, OR = odds ratio with respect to RA; p = p value for association; RA = risk allele; SNP = single-nucleotide polymorphism.